Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | DrugBank | Drug (Description in trials) | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 |
Satralizumab
(Satralizumab) | [3] Enspryng Enspryng; Sapelizumab; SATRALIZUMAB | [1] Satralizumab
Satralizumab
(Satralizumab, Satralizumab, satralizumab-mwge) 💬
| [1] IL6R IL6R 💬
| [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [3] 11 11, 13, 86 💬
|